Cargando…

1562. Safety and Efficacy of High-Dose Cefazolin Therapy in Obesity

BACKGROUND: Obesity leads to altered pharmacokinetics through changes in volume of distribution and clearance, which can impact antimicrobial dosing. Although there is data to support higher cefazolin pre-operative dosing for surgical prophylaxis, data evaluating treatment doses of cefazolin in obes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simpson, Timothy, Shah, Sneha, Pogue, Jason M, Wu, Janet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809175/ http://dx.doi.org/10.1093/ofid/ofz360.1426

Ejemplares similares

247. Evaluation of the Efficacy and Safety of Cefazolin in Non-Pneumococci Streptococcal Bacteremia
por: Wibisono, Arya, et al.
Publicado: (2023)

2250. Combination Vancomycin Plus Cefazolin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Combination Vancomycin/Cefazolin (VAN/CFZ) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Trinh, Trang D, et al.
Publicado: (2017)

1097. An Antimicrobial Stewardship Intervention to Optimize Cefazolin Dosing for Surgical Prophylaxis
por: Neuner, Elizabeth A, et al.
Publicado: (2019)

Prophylactic Cefazolin Dosing in Obesity—a Systematic Review
por: Coates, Matthew, et al.
Publicado: (2022)

1465. Two- versus Three-Gram Cefazolin Dosing for Surgical Prophylaxis in Colorectal Surgery Procedures
por: Collins, Curtis D, et al.
Publicado: (2023)

1057. Treatment Efficacy of Ceftriaxone vs. Cefazolin for Methicillin-Susceptible Staphylococcus aureus Infections
por: Bhavan, Kavita, et al.
Publicado: (2018)

1180. Empiric treatment of uncomplicated intraabdominal infection with cefazolin with or without metronidazole
por: Borkowski, Jaime, et al.
Publicado: (2023)

1562. Impact of Skin Biopsy on Diagnosing Infections and Changing Treatment in Cancer Patients with New Skin Rash
por: Jakharia, Niyati, et al.
Publicado: (2018)

346. Evaluation of the Safety Profile of Cefazolin Monotherapy in Outpatient Parenteral Antibiotic Antimicrobial Therapy at a Large Academic Medical Center
por: Poux, Nicolas, et al.
Publicado: (2023)

1562. Renal Outcomes after Switch from Oral Antiretroviral therapy (ART) to Long-acting injectable Cabotegravir/Rilpivirine (LAI CAB)
por: Ayala, Alvaro, et al.
Publicado: (2023)

Prophylactic Cefazolin Dosing and Surgical Site Infections: Does the Dose Matter in Obese Patients?
por: Hussain, Zahid, et al.
Publicado: (2018)

2391. Liposomal Vancomycin and Cefazolin Combinations for S. aureus Biofilms
por: Kebriaei, Razieh, et al.
Publicado: (2018)

2533. Cerebrospinal Fluid Penetration of Cefazolin and Flucloxacillin in Children
por: Boast, Alison, et al.
Publicado: (2023)

101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

1094. Safety of Administering Cefazolin vs. Other Antibiotics in Penicillin Allergic Patients with Anaphylaxis for Surgical Prophylaxis
por: Song, Wendy, et al.
Publicado: (2019)

Safety and Effectiveness of High-Dose Cefazolin in Patients With High Body Weight: A Retrospective Cohort Study
por: Ryu, HaYoung, et al.
Publicado: (2022)

1110. Outcomes Following Implementation of a Urine Culture
por: Simpson, Timothy, et al.
Publicado: (2019)

1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Caniff, Kaylee E, et al.
Publicado: (2023)

217. Combination Salvage Therapy with Cefazolin Plus Ertapenem for Refractory Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Rose Ulloa, Erlinda, et al.
Publicado: (2019)

2238. Effect of Cefazolin Breakpoint Update in Susceptibility Reports on Antimicrobial Use
por: Buckley, Valerie, et al.
Publicado: (2023)

Comparison the Efficacy of Cefazolin plus Gentamicin with Cefazolin plus Ciprofloxacin in Management of Type –IIIA Open Fractures
por: Janmohammadi, N, et al.
Publicado: (2011)

Visceral Leishmaniasis during Italian Renaissance, 1522–1562
por: Nerlich, Andreas G., et al.
Publicado: (2012)

738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia
por: Khodadadi, Ryan B, et al.
Publicado: (2022)

A randomized controlled trial to compare antibiotic prophylaxis in elective gynecological surgeries: Single dose of cefazolin versus single dose of cefazolin and tinidazole
por: Garg, Shivani, et al.
Publicado: (2021)

Efficacy and Safety of a Vancomycin (VAN) Dosing Protocol Developed for Morbidly Obese (MO) Patients
por: Taylor, Paige A, et al.
Publicado: (2017)

2063. Extracellular Release of β-Lactamase Is Responsible for the Cefazolin Inoculum Effect (CzIE) in Methicillin-Susceptible Staphylococcus aureus
por: Carvajal, Lina P, et al.
Publicado: (2018)

2262. Evaluation of Ceftriaxone Versus Cefazolin as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales Isolates
por: Lambert, Kaitlyn, et al.
Publicado: (2023)

1562. Reduction in Healthcare Utilization and Overdose after Skin and Soft Tissue Infections for Injection Drug Users through Addiction Medicine Consultation
por: Bielick, Catherine G, et al.
Publicado: (2020)

266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Mohamed, Adham, et al.
Publicado: (2020)

P1562: THE FIRST TWO YEARS OF THE EUROPEAN VACCELERATE VOLUNTEER REGISTRY
por: Salmanton-García, Jon, et al.
Publicado: (2023)

1562 The Influence of Co-infection with HCV on CD4 and B-cell Reconstitution in Human Immunodeficiency Virus (HIV)-infected Patients
por: Abers, Michael S., et al.
Publicado: (2014)

Cefazolin Pharmacokinetics in Premature Infants
por: Balevic, Stephen J., et al.
Publicado: (2019)

1067. Comparative Effectiveness of Nafcillin or Oxacillin, Cefazolin, and Piperacillin/Tazobactam in Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Beganovic, Maya, et al.
Publicado: (2018)

852. The Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children: Does It Matter?
por: McNeil, Jonathan C, et al.
Publicado: (2019)

Randomized controlled trial of cefazolin monotherapy versus cefazolin plus azithromycin single dose prophylaxis for cesarean deliveries: A developing country's perspective
por: Jyothi, Manjeera S., et al.
Publicado: (2019)

Pharmacokinetics and Optimal Dose Selection of Cefazolin for Surgical Prophylaxis of Pediatric Patients
por: Schmitz, Michael L., et al.
Publicado: (2020)

1661. Evaluation of Cefazolin < 3 g vs. 3 g Treatment Doses for Cellulitis in Patients Who Weigh ≥ 120 kg within a Large, Community Health System
por: Gens, Krista, et al.
Publicado: (2022)

2821. A Comparison of Empirical Therapy with Cefazolin Versus Ceftriaxone for the Treatment of Complicated Urinary Tract Infections in a Tertiary Care VA Medical Center
por: Carcamo, Paola, et al.
Publicado: (2023)

Is it just a cefazolin issue?
por: Takazawa, Tomonori, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_404li9m4mgtgth4o508ermgh82